Latest: Insecticides India Ltd Q1 FY27 (Apr–Jun 2026) results →This page is Q3 FY26 (Oct–Dec 2025).All Q3 FY26 results →
I

Insecticides India Ltd

Q3 FY26Fertilizers & Agrochemicals

Insecticides India Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Price₹610
Market cap₹1.8K Cr
P/E14.7
Updated23 Aug 2026
Read4 min read

The short version

The company targets a sustainable growth of 8% to 10% over the next 2 to 3 years. Company targets low double-digit EBITDA margins for the full year, with a cautious improvement expected beyond that (Pages 16-17).

From Insecticides India Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • The company targets a sustainable growth of 8% to 10% over the next 2 to 3 years.
  • Growth for FY '27 is expected to be cautiously positive, with recovery signs starting in Q1.
  • At least 5 new product launches are planned in Q1 of FY '27, including specialty and proprietary products.
  • The focus is on premiumization and specialty products, which command higher farmer investment and improve margins.
  • Volume-led growth is anticipated, with B2B segment growing approximately 15% and B2C segment around 3-4%.
  • The company expects improved profitability with better product mix, operational efficiency, and working capital management.

2 more points from Insecticides India Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Insecticides India Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • New formulation and technical plant at Dahej site is operational and expected to improve performance in FY '27.
  • Sotanala facility: formulation plant to start Q1 of FY '27, technical plant expected in 2027.
  • Capex focused on capacity creation and maintenance aligned with medium-term growth priorities.
  • Backward integration planned selectively for specialist products to gain cost advantage and improve profitability.
  • Investment decisions based on ROCE and ROE; non-essential capex being frozen to rationalize business.
  • Strategy includes expanding technical capacity selectively; building new technical plants typically takes around 2-3 years.

2 more points from Insecticides India Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
2Dharmaj Crop
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Insecticides India Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Some related points include: - Focus on selective sales in Q4 with faster conversion on identified geographies, crops, and accounts to protect top line and market share. - Emphasis on strict pricing floors and order-wise profitability tracking in B2B sales. - Continued traction from new product launches contributing to order flow and demand. - International business is gradually gaining traction with registrations underway in markets like Latin America and Australia.

2 more points from Insecticides India Ltd's call on order book

Create a free account to keep reading this call

Insecticides India Ltd — Quarterly revenue & net profit

Revenue Net profit
Sep 2024Q2 FY25
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26

Reported quarterly figures (₹ Cr). Latest (Q3 FY26): revenue ₹385 Cr, net profit ₹10 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Bhagiradha Chem. (Q3 FY26)

    114.0 crore, up 11% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q3 FY26 investor presentation — and how it ran

  • Advance Agrolife (Q3 FY26)

    Q3 FY26 revenue from operations was ₹1,338 million, up 18% year-on-year (YoY) from ₹1,134 million in Q3 FY25 (Pages 23-24). Key investor presentation takeaways

  • Khaitan Chemical (Q3 FY26)

    Q3-FY26 operational revenue: INR 2,657 million, up 34% year-on-year (Page 23, 24). Key investor presentation takeaways from Khaitan Chemical's Q3 FY26 investor

  • Rama Phosphates (Q3 FY26)

    Q3 FY26 Revenue from Operations: ₹23,800 lakhs, up 33% YoY (Q3 FY25: ₹17,962 lakhs) [Page 9] . Key investor presentation takeaways from Rama Phosphates's Q3 FY2

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Insecticides India Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Insecticides India Ltd Q3 FY26 results?

The company targets a sustainable growth of 8% to 10% over the next 2 to 3 years. Company targets low double-digit EBITDA margins for the full year, with a cautious improvement expected beyond that (Pages 16-17).

What is Insecticides India Ltd share price analysis?

Insecticides India Ltd currently shows a neutral. The stock trades at a P/E of 14.7 with a market cap of ₹1,837 Cr. Investors should review the full earnings analysis for detailed insights.

Is Insecticides India Ltd planning capital expenditure?

New formulation and technical plant at Dahej site is operational and expected to improve performance in FY '27.

Keep Insecticides India Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.